🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 747324101
- Market Cap
- Micro Cap
- IPO
- 10/8/2021 · $16.00/share
Business: Pyxis Oncology, Inc. is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. Pyxis develops its product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion.
Company Contact
- CEO
- Thomas Civik
- CFO
- Balu Balasubramanian
- Headquarters
- 321 Harrison Avenue, Boston,, MA 02118
- Phone
- 617-221-9059
- Investor Relations
- Ashley Robinson, LifeSci Advisors, LLC · arr@lifesciadvisors.com